Short-term myocardial infarction experiments, along with complementary murine studies, revealed that Agrin’s mechanisms of action include myocardial protection, improved angiogenesis, inflammatory suppression, and cell cycle reentry. This evidence concerns the gene AGRN and myocardial infarction.